Saadia supports biotech and pharma companies at critical growth junctures. Areas she advises in include program prioritization and go/no go decisions, disease area and indication prioritization, partnering strategy.
Her experience includes technical and commercial assessment/due diligence of therapeutics, out-licensing, technology scouting/in-licensing, asset valuations, therapeutic area strategy and product development strategy.
Saadia holds an Honours degree in Biomedical Informatics, a Master of Science degree in Molecular Medicine and a PhD in Neuroendocrinology from Imperial College.
In-licensing & Asset scouting
Out-licensing, Partnering & Deal-making
Clinical development strategy & Clinical development services